Heron Therapeutics to Present at the 2022 Jefferies Global Healthcare Conference

SAN DIEGO, May 26, 2022 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing therapeutic innovations that improve medical care, today announced that company management…

Click here to view original post